Showing results (3621-3630 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 16, 2018
Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular InvasionShuang Liu, Hui Li, Lei Guo, et al.
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
The Oncologist|March 30, 2018
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid TumorsGerald Edelman, Jordi Rodon, Joanne Lager, et al.
The Oncologist|March 30, 2018
Development and Validation of a Clinical Score for Cardiovascular Risk Stratification of Long-Term Childhood Cancer SurvivorsEvangelos K Oikonomou, Sofia G Athanasopoulou, Polydoros N Kampaktsis, et al.
The Oncologist|August 4, 2007
Some aspects of the endocrine profile and management of hormone-dependent male breast cancerNikolay V Dimitrov, Philomena Colucci, Sunil Nagpal
The Oncologist|August 4, 2007
Delays in cancer diagnosis in underinsured young adults and older adolescentsSean Martin, Corinne Ulrich, Mark Munsell, et al.
The Oncologist|August 4, 2007
Erlotinib in non-small cell lung cancer treatment: current status and future developmentCesare Gridelli, Maria Anna Bareschino, Clorinda Schettino, et al.
The Oncologist|October 5, 2007
How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovariesZeev Blumenfeld
The Oncologist|October 5, 2007
Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injuryKutluk Oktay, Murat Sönmezer, Ozgür Oktem, et al.
The Oncologist|July 25, 2008
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient managementValentina Guarneri, Simona Giovannelli, Guido Ficarra, et al.
Pageof 571